Composition
- Active ingredients
- RESERPINE 0.1MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RESERPINE 0.25MG · TabletANDA080446-001 · Discontinued
- RESERPINE 0.25MG · TabletANDA080582-001 · Discontinued
- RESERPINE 1MG · TabletANDA080582-002 · Discontinued
- RESERPINE 0.25MG · TabletANDA080975-002 · Discontinued
- RESERPINE 1MG · TabletANDA080975-003 · Discontinued
- RESERPINE 0.1MG · TabletANDA080975-001 · Discontinued
- RESERPINE 0.1MG · TabletANDA089020-001 · Discontinued
- RESERPINE 0.1MG · TabletNDA009627-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA009627-002 · Discontinued
- RESERPINE 0.1MG · TabletThis page
- RESERPINE 0.25MG · TabletNDA009667-002 · Discontinued
- RESERPINE 0.1MG · TabletNDA009859-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA009859-002 · Discontinued
- RESERPINE 0.25MG · TabletANDA080637-001 · Discontinued
- RESERPINE 0.25MG · TabletANDA084663-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA011185-002 · Discontinued
- RESERPINE 0.1MG · TabletNDA011185-001 · Discontinued
- RESERPINE 1MG · TabletANDA080457-003 · Discontinued
- RESERPINE 0.25MG · TabletANDA080457-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA009667.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Reserpine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Valeant Pharm Intl
- Status
- Discontinued
- Application
- NDA009667-001